Aptus Pharma Q2 Results
- BSE: 544529
- NSE: -
- ISIN: INE15XJ01010
- Sector: Biotechnology & Drugs
BSE
314.50
14.95 (4.99%)
14.95 (4.99%)Volume14.00 K
Updated: Thu 12 Mar, 2026 | 12:46:16
NSE
This stock is not traded on NSE
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹14.38 Cr.-
- Operating Profit₹2.79 Cr.(NA%)
- Profit After Tax₹1.75 Cr.-
- Operating Margin19.42%(NA%)
Note: Comparison is on YoY basis
Quarterly - Aptus Pharma Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | - | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 11.59 | - | N/A | - | N/A |
| Depreciation/ Amortization | 0.16 | - | N/A | - | N/A |
| Operating Income | 2.79 | - | N/A | 0.00 | 0.00% |
| Net Income | 1.75 | - | N/A | - | N/A |
| Other Operating Expenses Total | 3.30 | - | N/A | - | N/A |
| Net Income Before Taxes | 2.35 | - | N/A | - | N/A |
| Total Revenue | 14.38 | - | N/A | 0.00 | 0.00% |
| Selling/ General/ Admin Expenses Total | 2.30 | - | N/A | - | N/A |
| Diluted Normalized EPS | 2.55 | - | N/A | - | N/A |